Matthew Gline

CIK: 0001750094

Transaction Breakdown

Open Market Buys (P)1 (3.4%)

High conviction signal

Open Market Sales (S)5 (17.2%)

Position reduction

Option Exercises (M)5 (17.2%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)18 (62.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ROIV

Roivant Sciences Ltd.

DirectorOfficer

ABUS

Arbutus Biopharma Corp

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (29 total)

ROIV
Roivant Sciences Ltd.
Oct 16, 2026
Tax Payment(F)
Direct
34.6K shares at avg. $33.53$1.2M
ROIV
Roivant Sciences Ltd.
Sep 30, 2026
Tax Payment(F)
Direct
76.2K shares at avg. $36.57$2.8M
ROIV
Roivant Sciences Ltd.
Jun 30, 2026
Tax Payment(F)
Direct
76.2K shares at avg. $35.39$2.7M
ROIV
Roivant Sciences Ltd.
Apr 16, 2026
Sale(S)
Direct
289.8K shares at avg. $29.16$8.4M
ROIV
Roivant Sciences Ltd.
Mar 31, 2026
Tax Payment(F)
Direct
304.7K shares at avg. $27.70$8.4M
ROIV
Roivant Sciences Ltd.
Mar 30, 2026
Tax Payment(F)
Direct
53.8K shares at avg. $26.41$1.4M
ROIV
Roivant Sciences Ltd.
Mar 30, 2026
Exercise(M)
Direct
97.3K shares-
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Sale(S)
Direct
943.5K shares at avg. $21.68$20.5M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Other(J)
Direct
1.3M shares at avg. $21.68$28.8M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Sale(S)
Direct
230.4K shares at avg. $21.68$5.0M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Exercise(M)
Direct
234.1K shares at avg. $4.06$950K
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Other(J)
Direct
3.7K shares at avg. $21.68$81K
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Exercise(M)
Direct
1.4M shares at avg. $12.68$17.3M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Sale(S)
Direct
566.1K shares at avg. $21.68$12.3M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Other(J)
Direct
797.6K shares at avg. $21.68$17.3M
ROIV
Roivant Sciences Ltd.
Dec 15, 2025
Exercise(M)
Direct
2.3M shares at avg. $12.68$28.8M
ROIV
Roivant Sciences Ltd.
Sep 18, 2025
Purchase(P)
Direct
3.3K shares at avg. $15.07$50K
ROIV
Roivant Sciences Ltd.
May 20, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $11.04$121K
ROIV
Roivant Sciences Ltd.
Apr 20, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $10.15$111K
ROIV
Roivant Sciences Ltd.
Mar 20, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $10.97$120K
ROIV
Roivant Sciences Ltd.
Feb 20, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $10.72$117K
ROIV
Roivant Sciences Ltd.
Jan 20, 2025
Tax Payment(F)
Direct
11.6K shares at avg. $11.15$130K
ROIV
Roivant Sciences Ltd.
Dec 20, 2024
Tax Payment(F)
Direct
10.9K shares at avg. $11.57$127K
ROIV
Roivant Sciences Ltd.
Nov 20, 2024
Tax Payment(F)
Direct
10.9K shares at avg. $11.49$126K
ROIV
Roivant Sciences Ltd.
Oct 20, 2024
Tax Payment(F)
Direct
10.9K shares at avg. $11.92$130K

		Type	Shares	Price		Ownership
Oct 16, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	34,638	$33.53	$1,161,412	Direct
Sep 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	76,171	$36.57	$2,785,573	Direct
Jun 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	76,171	$35.39	$2,695,692	Direct
Apr 16, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	289,774	$29.16	$8,449,810	Direct
Mar 31, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	304,684	$27.70	$8,439,747	Direct
Mar 30, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	53,826	$26.41	$1,421,545	Direct
Mar 30, 2026	ROIV Roivant Sciences Ltd.	Exercise(M)	97,319	-	$0	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	943,527	$21.68	$20,455,665	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Other(J)	1,329,325	$21.68	$28,819,766	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	230,357	$21.68	$4,994,140	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Exercise(M)	234,096	$4.06	$950,430	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Other(J)	3,739	$21.68	$81,062	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Exercise(M)	1,363,711	$12.68	$17,291,855	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	566,116	$21.68	$12,273,395	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Other(J)	797,595	$21.68	$17,291,860	Direct
Dec 15, 2025	ROIV Roivant Sciences Ltd.	Exercise(M)	2,272,852	$12.68	$28,819,763	Direct
Sep 18, 2025	ROIV Roivant Sciences Ltd.	Purchase(P)	3,315	$15.07	$49,957	Direct
May 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$11.04	$120,833	Direct
Apr 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$10.15	$111,092	Direct
Mar 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$10.97	$120,067	Direct
Feb 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$10.72	$117,330	Direct
Jan 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	11,623	$11.15	$129,596	Direct
Dec 20, 2024	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$11.57	$126,634	Direct
Nov 20, 2024	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$11.49	$125,758	Direct
Oct 20, 2024	ROIV Roivant Sciences Ltd.	Tax Payment(F)	10,945	$11.92	$130,464	Direct

1-25 of 29 transactions

About Gline Matthew

Gline Matthew (SEC CIK 0001750094) files insider reports with the SEC as CEO of Roivant Sciences Ltd. (ROIV) and Director of Arbutus Biopharma Corp (ABUS).

Signal8 holds 17 ownership filings by Gline Matthew (1 Form 3, 16 Form 4), filed between Sep 24, 2024 and Oct 20, 2026. Those filings report 29 transactions, from Sep 20, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gline Matthew's filings is in LONDON.

Recent filings by Gline Matthew

Oct 16, 2026: Tax withholding of ROIV shares (Form 4, code F).
Sep 30, 2026: Tax withholding of ROIV shares (Form 4, code F).
Jun 30, 2026: Tax withholding of ROIV shares (Form 4, code F).
Apr 16, 2026: Open-market sale of ROIV shares (Form 4, code S).
Mar 31, 2026: Tax withholding of ROIV shares (Form 4, code F).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
Epperly Melissa B,, Director
MOMTAZEE JAMES C, Director
Sukhatme Mayukh, President & CIO
Torti Frank, President and Vant Chair

How to read Form 4 transaction codes